BBLG

Bone Biologics
BBLG

Overview Fund Trends Analyst Outlook Journalist POV

3 hedge funds and large institutions have $20.8K invested in Bone Biologics in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.08K
2
+$4

Top Sellers

1
-$20.6K
2
-$13K
3
-$4.65K
4
TRCT
Tower Research Capital (TRC)
New York
-$1.25K
5
SS
SBI Securities
Japan
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$19.4K
TRCT
2
Tower Research Capital (TRC)
New York
$1.46K
Bank of America
3
Bank of America
North Carolina
$17
SS
4
SBI Securities
Japan
$1
UBS Group
5
UBS Group
Switzerland
–
HF
6
HRT Financial
New York
–
Citigroup
7
Citigroup
New York
–